$68.49
al cierre: Oct 29 EDT
$68.48
-0.01000-0.01%
Pre-comercialización: 4:03 AM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Inhibrx Biosciences informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 13
Estimación de BPA
$-2.210
Estimación de ingresos trimestrales
–
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$1.40M
Analice el historial de beneficios de Inhibrx Biosciences utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
INBX | Inhibrx Biosciences | -$2.84 | -$2.21 | — | — | $0.00 | — | — | — | 11/13/2025 | |
INBX | Inhibrx Biosciences | $125.48 | -$2.73 | -$1.85 | 32.23% | $100.00K | — | $1.30M | — | 08/13/2025 | |
INBX | Inhibrx Biosciences | -$5.77 | -$3.45 | -$2.80 | 18.84% | $0.00 | — | $0.00 | — | 05/14/2025 | |
INBX | Inhibrx Biosciences | -$6.93 | -$2.88 | -$3.09 | -7.29% | $1.63M | — | $100.00K | — | 03/17/2025 | |
INBX | Inhibrx Biosciences | -$4.39 | -$3.81 | -$2.84 | 25.46% | $119.00K | — | $0.00 | — | 11/14/2024 | |
INBX | Inhibrx Biosciences | -$4.31 | -$1.47 | $125.48 | 8636.05% | $30.00K | — | $100.00K | — | 08/13/2024 | |
INBX | Inhibrx Biosciences | -$1.12 | -$1.51 | -$1.44 | 4.64% | $17.00K | — | $0.00 | — | 05/09/2024 | |
INBX | Inhibrx Biosciences | -$0.95 | -$1.04 | -$1.73 | -66.35% | $274.00K | $50.00K | $1.63M | 3168.00% | 02/28/2024 | |
INBX | Inhibrx Biosciences | -$0.90 | -$1.01 | -$1.10 | -8.91% | $278.00K | — | $119.00K | — | 11/09/2023 | |
INBX | Inhibrx Biosciences | -$0.97 | -$1.03 | -$1.08 | -4.85% | $711.00K | — | $30.00K | — | 08/07/2023 | |
INBX | Inhibrx Biosciences | -$0.80 | -$0.84 | -$1.12 | -33.33% | $929.00K | $150.00K | $17.00K | -88.67% | 05/08/2023 | |
INBX | Inhibrx Biosciences | -$0.55 | -$0.79 | -$0.95 | -20.25% | $2.86M | $790.00K | $274.00K | -65.32% | 03/06/2023 | |
INBX | Inhibrx Biosciences | -$0.54 | -$0.94 | -$0.90 | 4.26% | $2.53M | $630.00K | $278.00K | -55.87% | 11/07/2022 | |
INBX | Inhibrx Biosciences | -$0.55 | -$0.78 | -$0.97 | -24.36% | $954.00K | $1.07M | $711.00K | -33.55% | 08/08/2022 | |
INBX | Inhibrx Biosciences | -$0.51 | — | -$0.80 | — | $889.00K | — | $929.00K | — | 05/09/2022 | |
INBX | Inhibrx Biosciences | -$0.47 | — | -$0.55 | — | $2.78M | — | $2.86M | — | 02/28/2022 | |
INBX | Inhibrx Biosciences | -$0.77 | -$0.57 | -$0.54 | 5.26% | $5.90M | $1.00M | $2.53M | 153.20% | 11/09/2021 | |
INBX | Inhibrx Biosciences | -$0.99 | -$0.56 | -$0.55 | 1.79% | — | $820.00K | $954.00K | 16.34% | 08/09/2021 | |
INBX | Inhibrx Biosciences | -$1.11 | -$0.56 | -$0.51 | 8.93% | — | $920.00K | $889.00K | -3.37% | 05/13/2021 | |
INBX | Inhibrx Biosciences | — | — | -$0.47 | — | — | — | $2.78M | — | 03/12/2021 | |
INBX | Inhibrx Biosciences | -$1.11 | -$0.60 | -$0.77 | -28.33% | $1.22M | $1.00M | $5.90M | 490.10% | 11/13/2020 |
Inhibrx Biosciences (INBX) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-13 | $-1.85 | $-2.73 | 32.2 % |
| Q1 | 2025-05-14 | $-2.80 | $-3.45 | 18.8 % |
| Q4 | 2025-03-17 | $-3.09 | $-2.88 | -7.29 % |
| Q3 | 2024-11-14 | $-2.84 | $-3.81 | 25.5 % |
Inhibrx Biosciences (INBX) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q4 | 2024-02-28 | $1.63M | $50.00K | 3168.0 % |
| Q1 | 2023-05-08 | $17.00K | $150.00K | -88.7 % |
| Q4 | 2023-03-06 | $274.00K | $790.00K | -65.3 % |
| Q3 | 2022-11-07 | $278.00K | $630.00K | -55.9 % |
PREGUNTAS FRECUENTES
¿Cuándo Inhibrx Biosciences (NASDAQ:INBX) publicará los resultados?
Está previsto que Inhibrx Biosciences (INBX) presente resultados el noviembre 13, 2025. Los últimos resultados se publicaron el agosto 13, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Inhibrx Biosciences (NASDAQ:INBX)?
El BPA real fue de $-1.85, que superó la estimación de $-2.73.
¿Cuáles fueron los ingresos de Inhibrx Biosciences (NASDAQ:INBX)?
Los ingresos reales fueron $1.3M, que superó la estimación de $0K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.